• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Auna SA

    1/14/25 9:32:34 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)


    Auna S.A.

    (Name of Issuer)


    Class A Ordinary Shares, nominal value US$0.01 per share

    (Title of Class of Securities)


    L0415A103

    (CUSIP Number)


    Jose Luis Alberdi Gonzalez
    Camino a Santa Teresa 1055, piso 14, Heroes de Padierna
    La Magdalena Contreras, O5, 10700
    0052 (55) 5449-7488


    Manuel Silva
    Cleary Gottlieb Steen & Hamilton LLP, One Liberty Plaza
    New York, NY, 10006
    (212) 225-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    01/10/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    L0415A103


    1 Name of reporting person

    Grupo Angeles Servicios de Salud, S.A. de C.V.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    MEXICO
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,214,062.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,214,062.00
    11Aggregate amount beneficially owned by each reporting person

    7,214,062.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    24.05 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    The percent calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares (as defined below) outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer (as defined below) with the Securities and Exchange Commission (the "SEC") on March 25, 2024 pursuant to Rule 424(b)(1) under the Securities Act of 1933, as amended (the "Final Prospectus").


    SCHEDULE 13D

    CUSIP No.
    L0415A103


    1 Name of reporting person

    Grupo Vazol, S.A. de C.V. (Priorly known as Grupo Empresarial Angeles, S.A. de C.V.)
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    MEXICO
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,214,062.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,214,062.00
    11Aggregate amount beneficially owned by each reporting person

    7,214,062.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    24.05 %
    14Type of Reporting Person (See Instructions)

    HC

    Comment for Type of Reporting Person:
    The percent calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.


    SCHEDULE 13D

    CUSIP No.
    L0415A103


    1 Name of reporting person

    Corpvaza, S.A. de C.V.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    MEXICO
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,214,062.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,214,062.00
    11Aggregate amount beneficially owned by each reporting person

    7,214,062.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    24.05 %
    14Type of Reporting Person (See Instructions)

    HC

    Comment for Type of Reporting Person:
    The percent calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.


    SCHEDULE 13D

    CUSIP No.
    L0415A103


    1 Name of reporting person

    Mr. Olegario Vazquez Aldir
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    MEXICO
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,214,062.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,214,062.00
    11Aggregate amount beneficially owned by each reporting person

    7,214,062.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    24.05 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    The percent calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Ordinary Shares, nominal value US$0.01 per share
    (b)Name of Issuer:

    Auna S.A.
    (c)Address of Issuer's Principal Executive Offices:

    6, rue Jean Monnet, Luxembourg, LUXEMBOURG , L-2180.
    Item 1 Comment:
    Pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, this Amendment No. 2 (this "Amendment") amends and supplements the Schedule 13D filed by Grupo Angeles Servicios de Salud, S.A. de C.V. ("GASS"), Grupo Vazol, S.A. de C.V. ("Vazol"), Corpvaza, S.A. de. C.V. ("Corpvaza"), and Mr. Olegario Vazquez Aldir ("Mr. Vazquez Aldir," and collectively with GASS, Vazol, and Corpvaza, the "Reporting Persons"), on August 22, 2024, and as amended and supplemented by Amendment No. 1 filed on September 12, 2024 (the "Schedule 13D"), relating to the Class A Ordinary Shares, nominal value US$0.01 per share (the "Class A Ordinary Shares"), of Auna S.A., a public limited liability company incorporated in Grand Duchy of Luxembourg ("Auna", or the "Issuer"). This Amendment amends the Schedule 13D on behalf of the Reporting Persons to furnish the information set forth herein, and except as set forth below, all Items of the Original Schedule 13D remain unchanged. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Schedule 13D.
    Item 3.Source and Amount of Funds or Other Consideration
     
    This Amendment amends and supplements Item 3 of the Schedule 13D as follows: From the date of the previously filed Schedule 13D on September 12, 2024, GASS purchased 554,062 Class A Ordinary Shares for a total purchase price of USD$3,903,890. GASS used available cash on hand to acquire such Class A Ordinary Shares.
    Item 5.Interest in Securities of the Issuer
    (a)
    The following disclosure assumes there are 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer with the SEC on March 25, 2024 pursuant to the Final Prospectus. Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own 7,214,062 shares of Class A Ordinary Shares, which constitutes approximately 24.05% of the outstanding Class A Ordinary Shares.
    (b)
    The information set forth in rows (7) through (10) of the cover pages of this Schedule 13D is incorporated by reference into this Item 5(b).
    (c)
    All transactions in Class A Ordinary Shares effected by the Reporting Persons and, to the best knowledge of the Reporting Persons, the Covered Persons within the prior 60-day window for which disclosure is required by Schedule 13D are listed in Schedule 2 hereto and incorporated herein by reference.
    Item 7.Material to be Filed as Exhibits.
     
    1. Agreement of Joint Filing by Grupo Angeles Servicios de Salud, S.A. de C.V., Grupo Vazol, S.A. de C.V., Corpvaza S.A. de C.V. and Olegario Vazquez Aldir dated as of August 22, 2024 (incorporated herein by reference to the Schedule 13D filed by Grupo Angeles Servicios de Salud, S.A. de C.V., Grupo Vazol, S.A. de C.V., Corpvaza S.A. de C.V. and Olegario Vazquez Aldir on August 22, 2024 with respect to the ordinary shares of Auna S.A.). 2. Schedule 2 - Item 5(c) - Transactions in Class A Ordinary Shares effected by the Reporting Persons.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Grupo Angeles Servicios de Salud, S.A. de C.V.
     
    Signature:/s/ Jose Luis Alberdi Gonzalez
    Name/Title:Jose Luis Alberdi Gonzalez/Legal Vice President
    Date:01/14/2025
     
    Grupo Vazol, S.A. de C.V. (Priorly known as Grupo Empresarial Angeles, S.A. de C.V.)
     
    Signature:/s/ Jose Luis Alberdi Gonzalez
    Name/Title:Jose Luis Alberdi Gonzalez/Legal Vice President
    Date:01/14/2025
     
    Corpvaza, S.A. de C.V.
     
    Signature:/s/ Jose Luis Alberdi Gonzalez
    Name/Title:Jose Luis Alberdi Gonzalez/Legal Vice President
    Date:01/14/2025
     
    Mr. Olegario Vazquez Aldir
     
    Signature:/s/ Jose Luis Alberdi Gonzalez
    Name/Title:Jose Luis Alberdi Gonzalez/Legal Vice President
    Date:01/14/2025
    Comments accompanying signature:
    Jose Luis Alberdi Gonzalez is signing on behalf of Mr. Vazquez Aldir pursuant to a power of attorney dated April 12, 2024, which was previously filed with the SEC as an exhibit to a Schedule 13G filed by Mr. Vazquez Aldir on April 12, 2024 (SEC File No. 005-94489).
    Get the next $AUNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    1/21/2026$6.90Hold → Buy
    HSBC Securities
    1/16/2026$9.00Buy
    Jefferies
    11/18/2025$6.00Overweight → Neutral
    Analyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in

    2/2/26 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces 3Q25 Financial Results

    Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 ("third quarter 2025" or "3Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjust

    11/20/25 4:45:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America

    Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America ("Sojitz"), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region's largest and fastest-growing healthcare markets. On September 24, 2025, Auna announced its intention to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico.

    11/20/25 4:30:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Auna S.A. upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Auna S.A. from Hold to Buy and set a new price target of $6.90

    1/21/26 8:29:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Jefferies initiated coverage on Auna S.A. with a new price target

    Jefferies initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $9.00

    1/16/26 8:40:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna S.A. downgraded by Analyst with a new price target

    Analyst downgraded Auna S.A. from Overweight to Neutral and set a new price target of $6.00

    11/18/25 8:17:10 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Auna SA

    SCHEDULE 13G/A - AUNA S.A. (0001799207) (Subject)

    1/5/26 1:27:35 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Auna SA

    SCHEDULE 13D/A - AUNA S.A. (0001799207) (Subject)

    12/2/25 6:35:34 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Auna SA

    6-K - AUNA S.A. (0001799207) (Filer)

    11/20/25 5:03:36 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    View All

    Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

    3/7/25 8:00:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

    12/19/24 9:01:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

    9/3/24 11:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Financials

    Live finance-specific insights

    View All

    Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in

    2/2/26 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces 3Q25 Financial Results

    Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 ("third quarter 2025" or "3Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjust

    11/20/25 4:45:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Reporting Dates for Third Quarter 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2025 financial results. Earnings Release Thursday, November 20, 2025 Time: After Market Close Conference Call Friday, November 21, 2025 Time: 8:00 a.m. ET Quiet Period Thursday, November 13 through Thursday, November 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with ope

    10/29/25 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/14/24 2:22:37 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Auna SA

    SC 13G/A - AUNA S.A. (0001799207) (Subject)

    11/13/24 10:53:24 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/12/24 6:09:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care